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A B S T R A C T
Basement membranes are specialized extracellular matrices that underlie arterial wall endothelial cells, with
laminin being a key structural and biologically-active component. Hypochlorous acid (HOCl), a potent oxidizing
and chlorinating agent, is formed in vivo at sites of inflammation via the enzymatic action of myeloperoxidase
(MPO), released by activated leukocytes. Considerable data supports a role for MPO-derived oxidants in car-
diovascular disease and particularly atherosclerosis. These effects may be mediated via extracellular matrix
damage to which MPO binds. Herein we detect and quantify sites of oxidation and chlorination on isolated
laminin-111, and laminin in basement membrane extracts (BME), by use of mass spectrometry. Increased
modification was detected with increasing oxidant exposure. Mass mapping indicated selectivity in the sites and
extent of damage; Met residues were most heavily modified. Fewer modifications were detected with BME,
possibly due to the shielding effects. HOCl oxidised 30 (of 56 total) Met and 7 (of 24) Trp residues, and
chlorinated 33 (of 99) Tyr residues; 3 Tyr were dichlorinated. An additional 8 Met and 10 Trp oxidations, 14
chlorinations, and 18 dichlorinations were detected with the MPO/H2O2/Cl- system when compared to reagent
HOCl. Interestingly, chlorination was detected at Tyr2415 in the integrin-binding region; this may decrease
cellular adhesion. Co-localization of MPO-damaged epitopes and laminin was detected in human atherosclerotic
lesions. These data indicate that laminin is extensively modified by MPO-derived oxidants, with structural and
functional changes. These modifications, and compromised cell-matrix interactions, may promote endothelial
cell dysfunction, weaken the structure of atherosclerotic lesions, and enhance lesion rupture.
1. Introduction
The extracellular matrix (ECM) is a major component of nearly all
tissues, with this providing a complex framework and 3-dimensional
structure that supports associated cells and defines tissue structure. The
ECM has multiple functions including: a) providing mechanical strength
and elasticity; b) acting as a scaffold for cell adhesion and growth; c)
controlling cell migration and proliferation; d) binding signalling mo-
lecules, pro-enzymes, enzyme inhibitors and cytokines; and e) con-
trolling the activity of these materials [1–4]. ECM glycosaminoglycans
(GAGs, polymers of acidic or sulfated sugars) can form gels of varying
pore size and charge density and thereby regulate molecular traffic.
Proteoglycans (proteins with covalently-attached glycosaminoglycan
chains) bind secreted signalling molecules (e.g. growth factors, cyto-
kines) and can enhance or inhibit their activity via multiple mechan-
isms including: (1) immobilization thereby restricting range of action;
(2) steric blocking of active sites; (3) providing a reservoir for delayed
release; (4) protection from proteolytic degradation thereby prolonging
action; (5) via alteration or concentration of the protein for presenta-
tion to cell-surface receptors. Alterations may therefore modulate cell
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behaviour (e.g. loss of adhesion and enhanced proliferation), and tissue
structure, stability and function.
Recent studies have shown that the ECM is highly susceptible to
oxidative damage due to its high abundance, its low rate of turnover
(which can results in accumulation of damage during ageing and dis-
ease) and the relatively low levels of extracellular antioxidant, repairs
and catabolic systems [5–7]. Considerable data has been presented that
demonstrates that oxidants generated by activated leukocytes (neu-
trophils, monocytes, tissue macrophages) can induce structural and
functional changes to ECM proteins and proteoglycans (proteins with
covalently attached GAGs), with damage evident in multiple tissue
samples, including within human atherosclerotic lesions [7–11].
Atherosclerosis is characterized by chronic inflammation, large
numbers of activated leukocytes, lipid accumulation, endothelial cell
dysfunction, smooth muscle cell migration and proliferation, loss of
elasticity, calcification and in some cases lesion rupture and thrombus
formation (reviewed [12,13]). Convincing data has been presented for
the presence of elevated levels of oxidation products at both extra- and
intra-cellular sites within plaques (e.g. [14–16]). The majority of this
protein damage appears to be present on ECM materials [17].
The presence of elevated numbers of activated neutrophils and
monocytes in the inflamed artery wall is known to increase plasma and
tissue levels of the heme enzyme myeloperoxidase (MPO) as a result of
release of this protein into the extracellular compartment or phagoly-
sosomes, from intracellular storage granules [18–20]. MPO catalyses
the formation of the potent oxidant and chlorinating agent HOCl from
hydrogen peroxide (H2O2) and chloride ions (Cl-) [21,22]. HOCl is
important in the killing of invading pathogens, but excessive or mis-
placed generation can generate host tissue damage [18,23–25]. Ex-
posure of cells to HOCl causes enzyme inactivation, membrane mod-
ification, dysregulated signalling, and cell death by necrosis and
apoptosis [18,19]. Elevated MPO and HOCl levels have been implicated
in multiple pathologies associated with inflammation, including cardi-
ovascular diseases amongst others [18,19].
Evidence has been presented for elevated MPO mRNA, protein and
enzyme activity in human atherosclerotic lesions [16,26] compared to
healthy artery sections. Elevated plasma MPO levels have also been
detected in subjects with established cardiovascular disease [27–30].
Biomarkers of HOCl-mediated damage are present at elevated levels in
human atherosclerotic lesions, including protein-bound 3-chlorotyr-
osine [16,26], chlorinated nucleobases [31,32], deaminated amino
acids [33], chlorinated lipids [34] and (lipo)proteins [16,35]. Strong
correlations have been demonstrated between the extent of MPO-
mediated damage and disease severity [16,36], and mice transgenic for
human MPO, which have elevated levels of MPO, suffer from increased
atherosclerosis [37]. Multiple epidemiological studies have shown that
MPO is an independent risk factor for coronary artery disease, and a
prognostic agent for determining outcomes in patients with cardiovas-
cular disorders [27–30,38].
The basement membrane (BM) is a specialized ECM structure that
underlies the endothelial cells of the artery wall, and prevents smooth
muscle cell infiltration into the intimal space [4]. It is rich in laminins,
type IV collagen, nidogen, entactin, perlecan amongst others [2,4].
These species play a critical role in determining the architecture of
basement membranes, with laminins being a particularly important
component, as their hetero-trimeric structure (one α-, one β- and one γ-
chain), allows cross-links to be formed between the N-termini to form
extensive laminin sheets [3,39]. The C-terminus of the longest (α) chain
binds to integrins, α-dystroglycan, heparan sulfates and sulfated gly-
colipids on cell surfaces, and therefore plays a critical role in cell ad-
hesion. Binding sites for agrin and nidogen function as a link between
the collagen-IV network and other ECM molecules [40]. The structure
and morphology of ECM components is known to change during
atherogenesis, and particularly within the fibrotic cap that stabilizes
lesions and prevents plaque rupture [12,41].
As MPO is released extracellularly and binds strongly to poly-an-
ionic materials such as GAG chains [42,43], the oxidants that it gen-
erates are likely to react rapidly and to a significant extent with ECM
proteins. We therefore hypothesized that both reagent HOCl, and the
MPO/H2O2/Cl- system, would induce significant chemical and struc-
tural changes to laminin, and that this would modulate the chemical
composition, structure and function of this protein. Previous studies
have provided evidence for extensive degradation of ECM by HOCl and
MPO-derived species [44–47], but the exact sites of damage are, in
general, poorly characterized. Recently, we have reported a detailed
analysis of HOCl-mediated damage to fibronectin [48]. In the current
study, we have extended this approach to characterize HOCl and MPO-
mediated damage to isolated laminin-111 (used as model protein), and
BM extracts (BME), by use of mass spectrometry (MS), as well as ex-
amining the possible presence of HOCl-derived matrix damage in
human atherosclerotic lesions.
2. Materials and methods
2.1. Reagents and buffers
Murine laminin-111 was purchased from Sigma Aldrich, and murine
BME (with reduced growth factors, Cultrex) was purchased from
Trevigen. Laminin concentrations were calculated using a protein mo-
lecular mass of 722 kDa, based on data from Uniprot entries P19137,
P02469, P02468 for the α-1, β-1 and γ-1 subunits respectively. This
molecular mass was also used to calculate laminin concentrations in the
BME where laminin is the major component. Lysyl endopeptidase (Lys-
C) was purchased from Wako, and trypsin from Sigma Aldrich. MPO
was from Planta Natural Products. All solvents and reagents were MS
grade, purchased from Sigma Aldrich, unless otherwise stated. The
following antibodies were used: rat anti-mouse laminin (clone AL-2; R&
D Systems, MN, USA), mouse anti-laminin γ1 (clone 2E8; Merck-
Millipore, MA, USA) and a mouse monoclonal against HOCl-modified
epitopes (clone 2D10G9) [49]. Biotinylated or HRP-conjugated sec-
ondary antibodies used for ELISA and immunoblotting experiments
were all from GE (IL, USA). Goat anti-mouse cyanine-2 (Cy-2)-labelled
IgG was from Jackson Dianova.
2.2. Oxidation of laminin-111 and BME
Murine laminin-111 or murine BME were suspended in 100mM
sodium phosphate buffer (PBS), pH 7.4, at a concentration of
1mgmL−1. Treatment with HOCl was carried out by bolus addition of
0, 100 and 500 μM HOCl and incubation for 1 h at 21 °C. Stock con-
centrations of HOCl were quantified using a molar extinction coefficient
(ε292) of 350M−1 cm−1 [50]. Enzymatic treatment was carried out at
37 °C by addition of 0.1 μM MPO, 500 μM H2O2, and 100mM NaCl.
Controls omitted NaCl, H2O2, or MPO, as well as an untreated protein.
H2O2 was added in 50 μM portions at 10min intervals to minimize
auto-inactivation of MPO by high concentrations of H2O2.
2.3. Quantification of HOCl-formation by the MPO system
HOCl production by the MPO/H2O2/Cl- system was quantified
spectrophotometrically at 290 nm, using the decrease in the mono-
chlorodimedone (MCD, 1M stock) absorbance resulting from MCD
oxidation, with a molar extinction coefficient ε290 of 17 700M−1 cm−1
[51].
2.4. Protein digestion and analysis by mass spectrometry
Laminin-111 (100 μg) was digested in-solution as described
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previously [48]. Briefly, exchange of the buffer to 50mM triethyl am-
monium bicarbonate supplemented with 4M urea and 1% sodium
deoxycholate (SDC) was carried out for 3 h or overnight at 21 °C using
10 kDa spin-filters (Amicon Ultra-0.5 Ultracel-10K, Merck Millipore,
Ireland) to remove residual reactants and salts. Digestion was per-
formed in two steps using Lys-C (2 h in 4M urea), followed by trypsin
(18 h in 1M urea) at 30 °C to minimize protein carbamylation. SDC was
subsequently removed by acidification and ethyl acetate phase transfer
[52].
The resulting peptide mixture (1 μg) was analysed on a QExactive
HF (Thermo Fisher Scientific) using data-dependant acquisition as de-
scribed previously [48]. Full scans of m/z 400–1400 was recorded with
120,000 resolution, and the top 12 most intense ions were selected for
HCD fragmentation using a normalised collision energy (NCE) of 28.
Blanks were included between each sample to monitor and prevent
carry-over. Data files (.raw, Xcalibur) were analysed using Progenesis
QI for proteomics (nonlinear Dynamics, USA) for chromatographic
alignment and precursor peak quantification. Proteome Discoverer 2.1
was used for database searches against a murine laminin isoform da-
tabase. The following search parameters were used: parent ion toler-
ance: 4 ppm; fragment ion tolerance: 0.1 Da; trypsin: 2 missed clea-
vages; fixed modifications: none; variable modifications: chlorination at
Tyr (Y) and Trp (W), dichlorination at Y and W, mono-oxidation at Met
(M), His (H), Cys (C) and W, di-oxidation at M,C,W, and tri-oxidation at
C. The peptide identifications were exported as pepXML files and im-
ported into Progenesis QI for analysis. The resulting data were exported
as comma-delimited files (.csv) providing normalised abundance cal-
culated from the extracted ion chromatograms of precursor ions [53].
Peptide identifications were validated manually as described previously
[48]. For chlorinated peptides, the isotopic distribution was inspected
relative to the native peptide to confirm the characteristic enhancement
of the 3rd isotopic isomer arising from the presence of chlorine isotopes
[54].
2.5. Quantification of total 3-chlorotyrosine levels by mass spectrometry
(MS)
Laminin-111 (25 µg) was treated with MPO (100 nM), Cl- (100mM),
and varying concentrations of H2O2 for 2 h at 37 °C. The H2O2 was
added in 50 µM aliquots over 10min intervals. The proteins were then
processed and analysed for total 3-chlorotyrosine (3-ClTyr) as described
previously [48], using 3-chloro-[13C6]tyrosine (100 pmol) as an in-
ternal standard [55]. MS experiments which examined TCA precipita-
tion versus spin filters versus for protein purification showed that the
use of TCA did not induce artefactual chlorination (T. Nybo, M.J. Da-
vies, A. Rogowska-Wrzesinska, unpublished data).
2.6. Quantification of methionine oxidation and methionine sulfoxide
formation by amino acid analysis
Laminin-111 was treated with MPO-derived HOCl, precipitated with
TCA, hydrolysed with MSA, and then neutralized, as described above
and previously [48]. The samples were subsequently filtered (0.2 µm,
Pall Nanosep filters), diluted 10-fold with MilliQ water, then 40 μL
transferred into vials for analysis using UPLC with pre-column deriva-
tization using o-phthaldialdehyde (OPA) and fluorescence detection
[48,56].
2.7. Analysis of structural changes on laminin using SDS-PAGE with silver
staining and immunoblotting
Laminin-111 samples (0.7 μM from a stock solution of 0.5mg pro-
tein mL−1) were treated with the indicated molar excesses of HOCl for
2 h at 37 °C. For gels run under reducing conditions the samples were
then treated with 10x reducing buffer for 10min at 70 °C. Enzyme
treated samples were generated in a similar manner to that outlined
above. For 12-well 3–8% tris acetate gels, 8 μL of sample were then
loaded into each well, whereas for 15-well gels 5 μL of sample were
loaded. The gels were developed under a constant voltage of 160 V for
70min. Bands on the gels were detected using silver staining, as de-
scribed previously [9], or by immunoblotting [9] using a rat mono-
clonal anti-mouse laminin antibody (clone AL-2 1:20000 dilution) with
detection performed using a biotinylated anti-rat secondary antibody
(1:5000 dilution) and streptavidin-conjugated HRP (1:1000 dilution),
developed using an ECL reagent (Perkin Elmer, MA, USA) and imaged
with a chemiluminescence imager (Syngene, MD, USA).
2.8. Detection of myeloperoxidase-derived damage by ELISA
Laminin-111 (5 μgmL−1 in 0.1M PBS, pH 7.4) was coated onto
clear high adhesion 96-well plates over 1 h at 37 °C, or overnight at
4 °C. The wells were then washed twice with 200 μL PBS to remove any
non-bound protein. The protein in the wells were then incubated with
MPO (20 nM), Cl- (100mM) and H2O2 (at the indicated concentrations)
for 2 h at 37 °C. The wells were washed twice with 200 μL PBS to re-
move residual oxidant, and then blocked with 100 μL 0.1% casein (w/v)
in PBS for 1 h at 21 °C. The wells were then washed twice with 200 μL
PBS before being incubated with 2D10G9 antibody [49] (50 μL; 1:100
dilution) overnight at 4 °C. Unbound antibody was removed
(2×200 μL PBS containing Tween 20) and then incubated with 50 μL
secondary antibody (alkaline phosphatase conjugated anti-mouse IgG;
1:1000 dilution) in 0.1% casein (w/v) in PBS for 1 h at 21 °C. Any
unbound secondary antibody was removed by washing (4×200 μL
TBST) before addition of 50 μL alkaline phosphatase yellow solution.
The absorbance of each well at 405 nm was then read every 5min over
a 30min period using a microplate reader.
2.9. Immunofluorescence analysis of human atherosclerotic lesions
Tissue samples from arteriae femuralis and aortae abdominalis were
obtained from 3 subjects (within 12 h post mortem) who died from
cerebral haemorrhage. Lesions were classified according to Stary and
coworkers [57] with these ranging from microscopically normal to
thickened intima (lesion type II-IV). The samples were frozen in a
cryostat (Microm HM500 OM; Microm, Walldorf, Germany) using
tissue-freezing medium (Tissue Tec OCT-compound; Miles, Elkhard,
Ind., USA). Serial cryosections (5 µm) were collected on glass slides, air-
dried (21 °C, 2 h), fixed in acetone (21 °C, 5min) and stored at − 70 °C
until examined [11,58]. Before analysis, sections were thawed and
fixed again in acetone (21 °C, 5min). PBS was used to rehydrate sec-
tions, followed by blocking with Ultra V block for 10min (Lab Vision,
Fremont, CA, USA). For double immunofluorescence staining, sections
were incubated first with monoclonal anti-laminin γ1 (mouse IgG, clone
2E8; 1:100 dilution) followed by goat anti-mouse Cy-2-labelled IgG
(1:300) as a secondary antibody [59]. After a blocking step with normal
mouse serum (1:25) for 15min sections were then incubated with Cy-3
labelled monoclonal antibody clone 2D10G9 (1:5) raised against HOCl-
modified epitopes [49]. PBS was used for washing steps and Dako an-
tibody diluent for antibody dilutions. All incubation steps were per-
formed at 21 °C in dark moisture chambers. The sections were mounted
with Moviol (Calbiochem-Novabiochem, La Jolla, USA), and analysed
with a confocal laser-scanning microscope in sequential mode (Leica
TCS SP2, Leica Lasertechnik GmbH, Heidelberg, Germany). Analysis for
Cy-2 (green staining) used λex 488 nm, and λem 500–540 nm, and for
Cy-3 (red staining) λex 543 nm, and λem 560–620 nm. Control experi-
ments were performed by omission of the primary antibodies or by
replacing them with non-immune mouse or rabbit IgG (Sigma-Aldrich).
This study was approved by the ethics committee from the Medical
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University Graz (EK-number: 29–464 ex 16/17). All methods were
performed in accordance with the relevant guidelines and regulations.
2.10. Statistics
For the MS data, statistical analysis was performed using Student's t-
test using SAS Enterprise Guide 7.1 (SAS Institute Inc., USA). One-way
ANOVA with post-hoc analysis using Dunnett's multiple comparison test
analysis was used for UPLC and ELISA data. Data are representative of
at least three independent experiments, with p < 0.05 considered
significant.
3. Results
3.1. HOCl induces chlorination and oxidation in murine laminin-111, and
laminin chains present in BME
The effects of HOCl (100, and 500 μM) and a MPO/H2O2/Cl- system
(with 500 μM H2O2 to generate the equivalent of 500 μM HOCl; see data
in [48]) on laminin-111 was studied using both purified murine protein
and a BME where laminin is a major component. Sites of modification
(chlorination and oxidation) were mapped and quantified by MS using
a recently described method ([48]; T. Nybo et al., submitted), in which
sequential Lys-C and tryptic digestion are performed without prior re-
duction and alkylation of the samples, as the latter have been shown to
interfere with the detection and quantification of some oxidative
modification ([60], T. Nybo et al., submitted). Use of this method re-
sulted in good sequence coverage for the globular domains (LN, L4, LF,
and LG) and the triple-helical long arm (I+II) of the untreated pure
protein (sequence coverage excluding the LE domains: α1 70.1%, β1
71.3%, γ1 64.0%), but relatively poor coverage of the laminin EGF-like
(LE) domains due to the high number of disulfide (cystine) cross-links in
these domains (Fig. 1). A small number of peptides specific to the α5,
β2 and γ3 chains were also detected in the samples (Table 1), together
with a small number of peptides common to both α1 and α5. The
presence of these peptides is likely to arise from the presence of low
amounts of contaminating α5, β2 and γ3 laminins in the commercial
preparation.
Treatment of purified laminin-111 with reagent HOCl (100 and
500 μM) for 1 h at 21 °C and pH 7.4, resulted in the consistent detection
(in at least two out of three experimental treatments, and none of the
controls) of oxidation at up to 31 Met, and 6 Trp residues, and chlor-
ination of up to 33 Tyr residues (Table 1). Annotated MSMS spectra are
given in Supplementary Fig. 1. A higher number of altered residues, and
a higher extent of modification at specific sites, were detected with 500
compared to 100 μM HOCl. A greater number of sites of modification
were detected on the α1 chain, compared to the β1 and γ1 chains
(Table 1). A small number of modifications were also detected on the
(contaminating) α5, β2 and γ3 chains (Table 1). The higher abundance
of modifications on the α1 chain compared to the other chains may
reflect a greater number of sites accessible for modification on the
longer α1 chain.
For the Met and Trp modifications, these were predominantly de-
tected as m/z+16 species, with these assigned to Met sulfoxide, and
hydroxylated products from Trp, respectively. Dioxygenation (m/
z+32 species) was also detected at a limited number of Trp residues
(Table 1). For the Tyr residues, these were detected as chlorinated (3-
ClTyr, m/z+34/36 ions) species, though 3 of these detected residues
were also detected as the di-chlorinated species, 3,5-Cl2Tyr. In a
number of cases, multiple oxidations were detected on the same pep-
tide, consistent with either the presence of multiple readily-modified
sites, or a clustering of damage. For example, the α1 chain peptide
2079MKDMEMQANLLLDR2092 was detected with two or three oxygen
atoms added (i.e. 2 or 3 Met sulfoxide species) at the 3 Met residues
present in this sequence (Table 1).
Treatment of the BME samples with reagent HOCl (100 or 500 μM)
reproduced 21 of the Trp and Met oxidation sites, and 10 of the Tyr
chlorination sites detected with purified laminin-111. In addition, one
novel 3-ClTyr site, two sites with 3,5-Cl2Tyr, two Met oxidation sites,
and two Trp oxidation sites were observed. This similarity in the sites of
modification suggests that a significant number of the positions in the
isolated purified trimeric protein that are accessible to HOCl, remain
accessible to the oxidant in the BME. However, the overall number of
sites of modification detected with the purified protein was significantly
greater than with the BME, suggesting that some regions of the protein
are shielded from modification by other components, or that less of the
oxidant reacts with the laminin chains in the BME samples.
3.2. The MPO/H2O2/Cl- system induces chlorination and oxidation in
murine laminin-111
Analogous experiments to those outlined above were carried out
using the MPO/H2O2/Cl- system to determine whether the enzyme
system gives rise to an altered distribution or extent of modification.
The majority of chlorination and oxidation sites detected on treatment
purified laminin with reagent HOCl were reproduced by the MPO/
H2O2/Cl- system (Table 1), though the enzyme system also induced
modifications at a considerable number of additional sites, including 8
sites of Met oxidation, 10 sites of Trp oxidation, and 14 additional Tyr
chlorination sites (Table 1). The number of sites with multiple mod-
ifications on a single residue (di-oxygenation, di-chlorination) was
significantly greater with the MPO/H2O2/Cl- system than with reagent
Fig. 1. Coverage map obtained for α, β, and γ-chains of murine laminin-111. Dark grey colouration indicates covered sequence, with light grey indicating missing
sequence. Domain structures (LN, LE etc) are indicated by dotted line boxes; percentage values on parentheses indicate sequences coverage of each domain. Regions
rich on disulfide bonds (cystines; indicated by red lines) are indicated. Overall length and % sequence coverage for each chain are indicated at the end of each map.
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Table 1
List of sites of oxidation (at Met, Trp) and chlorination (Tyr) identified in purified murine laminin-111 (1.18 μM) or laminin present in murine basement membrane extract
(ECM; 1 μg protein) treated with 0, 100, and 500 μM HOCl, or a MPO (100 nM)/H2O2 (500 μM)/Cl- (100mM) system in 100mM PBS, pH 7.4, for 1 h at 21 °C. Data are
presented in sequence residue order for each of the laminin chains. The modified residues are indicated together with type of modification and the detected peptide(s)
(with start and stop numbering) which contain these residues, with the modified amino acid highlighted. Modifications are coded as follows: Cl =3-chloroTyr; Cl2 =3,5-
dichloroTyr; 2 x Cl = two 3-chloroTyr modifications in the peptide at the indicated residues; O1=mono-oxygenation; O2=di-oxygenation; 2 x O, 3 x O, 4 x O = two,
three or four mono-oxygenations at residues within the peptide at the indicated residues. • indicates modification detected with the stated oxidant system.
(continued on next page)
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Table 1 (continued)
(continued on next page)
T. Nybo et al. Redox Biology 20 (2019) 496–513
501
Table 1 (continued)
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HOCl, as were the number of modifications detected on the (con-
taminating) α5, β2 and γ3 chains (Table 1). Experiments with the
MPO/H2O2/Cl- system and BME were not carried out as MPO is known
to bind to multiple BME components [61,62], with this potentially
confounding the data analysis.
3.3. Laminin is highly susceptible to damage induced by the MPO/H2O2/Cl-
system
The extent of modification at each of the identified sites of mod-
ification on laminin was evaluated by the relative site occupancy (RSO;
the % conversion of a specific site to a particular product) [63]. Fig. 2
shows the site assignment and RSO of the modifications induced by
500 μM HOCl and the MPO/H2O2/Cl- system (with 500 μM H2O2, and
hence ~ 500 μM HOCl [48]) on purified laminin (PL:HOCl and PL: MPO
respectively), and by 500 μM HOCl on laminin in the BME (BME:HOCl).
Peptide quantification data are presented in Supplementary Tables 1–3
and Supplementary Figs. 2–7. As indicated in Fig. 2A, the MPO-system
induced a markedly greater extent of modification than reagent HOCl,
particularly on the α1-chain. This difference was less dramatic with the
β1 and γ1 chains, suggesting that MPO may associate with, and hence
direct oxidation to particular regions on this chain.
Although fewer sites were identified on the laminin chains present
in the BME than with isolated laminin (Table 1), the RSO values de-
tected for the BME were generally comparable with those detected with
the HOCl-treated purified protein. These data are consistent with the
hypothesis that the composition, or the interactions between laminin
and other components in the BM, affect the regions of the protein that
are exposed to the oxidant.
3.4. Quantification of isobaric peptide forms
A number of peptides were detected that contained more than a
single site of modification with this resulting in the detection of isobaric
(identical mass) species. In some cases, these species could be separated
by chromatography on the basis of the altered hydrophobicity of the
peptide. Thus, Tyr638 and Tyr641 were both detected as sites of mod-
ification in the peptide, 630AEGLSLQPYEEYFNVVR646, with these re-
sidue being converted to 3-ClTyr and 3,5-Cl2Tyr (Fig. 3). Quantitative
data was obtained for both sites in this peptide, as the sequence position
of the chlorination delays the chromatographic elution to a higher de-
gree when the chlorination is present on Tyr641 compared to Tyr638.
Treatment of purified laminin with reagent HOCl resulted in 3-ClTyr
formation at both Tyr residues, with a greater extent of modification
(RSO) at Tyr638. Thus with 500 μM HOCl, the RSO at Tyr638 and Tyr641
were 6.5% and 2.2%, respectively, with additional formation of 3,5-
Cl2Tyr detected at Tyr638 with a RSO value of 0.25% (Fig. 4A). With the
MPO/H2O2/Cl- system, 3-ClTyr and 3,5-Cl2Tyr were detected at both
sites, however in this case the extracted ion chromatograms of the
mono-chloro species (3-ClTyr) were not resolved for the two sites, thus
the quantification data reported reflects the sum of the contribution at
the two sites (RSO 12.1%). For the di-chlorinated species, the data were
resolved with the RSO values for 3,5-Cl2Tyr formation being 2.71% and
0.95% for Tyr638 and Tyr641, respectively, and hence a greater extent of
reaction at Tyr638.
3.5. Oxidation of Met residues can result in neutral loss of methane sulfenic
acid (CH3SOH) that complicates quantification
Met sulfoxide has been shown previously to undergo a neutral loss
of CH3SOH [64], which may confound quantification. In the current
study, the peptide 2081DMEMQANLLLDR2092 containing two Met re-
sidues (Met2082 and Met2084) was detected with multiple modifications
induced by HOCl. Fig. 5 shows MS fragmentation spectra of the native
peptide, together with those for peptides with single oxidations (m/
z+16; sulfoxide formation) at Met2082 and Met2084, respectively. The
+16 Da mass shifts consistent with the addition of a single oxygen
atom, are marked (dotted grey lines) for the diagnostic ions, y9 for
Met2084 and b2 for Met2082. The ions y9 and y10 contain only Met2084,
and in the oxidised form, neutral loss of CH3SOH was observed for both
ions (Fig. 5C). Similarly, the b2 and b3 ions containing Met2082 show
CH3SOH loss when the modification is present at this site (Fig. 5B).
The concentration dependence of the changes in RSO values for
some of the modifications provides information on the susceptibility of
different residues to modification. Fig. 6A indicates the dose depen-
dence of oxidation of the Met2082 and Met2084 residues. The latter
shows a high susceptibility to oxidation under control conditions with a
background RSO of ~ 55% compared to ~ 2% for Met2082. With
100 μM HOCl, the parent peptide is nearly 100% depleted, and Met2084
shows a RSO of ~ 100%. With 500 μM HOCl, Met2084 is fully oxidised
and the extent of Met2082 oxidation is increased to 47%, indicating that
oxidation occurs at Met2084 in preference to Met2082. Somewhat dif-
ferent behaviour is seen with the peptide 1476KQDDADQDMMMAGM-
ASQAAQEAELNAR1502 which appears to be an oxidation ‘hotspot’ with
modification (m/z+16; sulfoxide formation) detected at all 4 Met re-
sidues in this sequence (Fig. 6B). Under control conditions, the native
peptide has a total RSO value (for mono-oxidation at one of the 4 Met
residues) of ~ 49%, and ~ 36% for di-oxidation (two sulfoxides). After
exposure to 100 μM HOCl, the parent and singly oxidised peptide forms
are depleted (Fig. 6B), with species containing three Met oxidations
being the dominant form (RSO ~ 51%). With 500 μM HOCl, this se-
quences has a RSO for tetra-oxidation (i.e. sulfoxide formation at all 4
Met residues) of ~ 88%, with tri-oxidation accounting for ~ 11%.
However, unlike the situation with the peptide 2081DMEMQANLL-
LDR2092 discussed above, the four Met residues in this peptide appear to
be oxidised in a random order, with no detectable preference for oxi-
dation at particular Met residues.
3.6. Quantification of total methionine and methionine sulfoxide levels by
amino acid analysis
In order to determine the total extent of Met modification, Met
sulfoxide formation, and whether further products were formed (cf. the
data above for extensive Met oxidation), amino acid analysis for carried
out for the complete protein exposed to the MPO/H2O2/Cl- system
(using 500 μM H2O2). Experiments were only carried out with this
system due to the amount of purified protein required, and its greater
biological relevance. The data obtained (Fig. 7A,B) confirm that MPO/
H2O2/Cl- depletes parent Met, and enhances Met sulfoxide formation,
with the extent of Met depletion (~ 11 pmoles lost) showing a high
percentage conversion (~ 73%) to the sulfoxide (~ 8 pmole increase).
These data confirm that Met sulfoxide is the major product formed from
Met residues in the complete protein sequence, and that this pathway
consumes a considerable proportion of the HOCl generated (~ 15%
based on the total Met and Met sulfoxide detected by this method). No
evidence was obtained for Met sulfone formation, but low levels of this
di-oxygenated species, or other products (cf. data in [65]) cannot be
excluded. The formation of other materials may account for the (small)
discrepancy between the quantity of Met lost and sulfoxide formed.
3.7. Quantification of total 3-ClTyr levels by amino acid analysis
Using a similar approach to that outlined above for Met oxidation,
total 3-ClTyr yields on the protein were determined by LC-MS analysis
for the MPO/H2O2/Cl- system. The data obtained (Fig. 7C) indicate (as
expected) that very low levels of 3-ClTyr were present in the control
samples, and that these are markedly elevated on treatment with the
MPO/H2O2/Cl- system (using 500 μM H2O2). Quantification of the 3-
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ClTyr detected, relative to H2O2 initially supplied (and hence HOCl
formed), indicates that this product accounts for ~0.22% of the HOCl
generated, indicating that this is a low abundance modification, as re-
ported previously [23,66].
3.8. Detection and quantification of MPO/H2O2/Cl--induced modifications
on laminin using ELISA
Previous studies have employed a monoclonal antibody, 2D10G9, to
detect HOCl-induced damage in biological samples (e.g.
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Fig. 2. Schematic of the domain structures in murine laminin-111 chains α1 (A), β1 (B), and γ1 (C) annotated with the sites of modification and numbering within
sequence (Y, chlorination at indicated Tyr residue; M, oxidation at indicated Met residue, W, oxidation at indicated Trp residue) and their relative site occupancy
with darker colours indicating increased extents of modification. Purified laminin-111 (2.27 μM) was treated with 500 μM HOCl or the MPO/H2O2/Cl- system with
500 μM H2O2. Murine basement membrane extract (BME; 1 μg protein) was treated with 500 μM HOCl. Reactions were carried out in 100mM sodium phosphate
buffer, pH 7.4, for 1 h at 21 °C before analysis, as indicated in the Materials and methods.
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[16,35,58,59,67]. This antibody was therefore used to examine the
formation of MPO/H2O2/Cl--induced epitopes on both isolated laminin-
111 using an ELISA assay, and also the presence of these epitopes in
human atherosclerotic lesions (see below) by immunofluorescence.
Treatment of isolated laminin-111 with the MPO/H2O2/Cl- system,
with varying amounts of H2O2, provided evidence for HOCl-generated
epitopes on laminin, detected by the 2D10G9 antibody, with greater
recognition observed with higher oxidant doses with statistically-sig-
nificant increases in recognition detected with the complete enzyme
system containing ≥10 μM H2O2 (Fig. 8). Little recognition was ob-
served for control (untreated) protein samples, or when individual
components of the enzyme system were omitted (data not shown). The
increase in recognition was not linear, as expected, due to the presence
of other reactive targets [23] on the protein.
Fig. 3. Fragment ion spectra of laminin α1 peptide 630AEGLSLQPYEE-
YFNVVR646. (A) without modification, with single chlorination at
Tyr638 (B), Tyr641(C), or both Tyr638 and Tyr641 (D), and dichlorination
at Tyr638 (E), or dichlorination at Tyr641 (F). Grey lines indicate the y6
and y9 ions showing mass shifts diagnostic for Cl (+34 Da) and Cl2
(+68Da) on Tyr638 and Tyr641, respectively. Retention time (RT) des-
ignates the time of elution for the given peptide. Data obtained from
murine laminin-111 (1.18 μM) treated with 0.1 μM MPO, 500 μM H2O2,
and 100mM NaCl. Annotated MS/MS spectra and fragment ion tables
for all identified peptides are presented in Supplementary Fig. 4.
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3.9. Structural changes induced on laminin by exposure to reagent HOCl
and a MPO enzyme system
The above data indicate that HOCl and the MPO/H2O2/Cl- system
can induce significant changes on laminin-111 at the residue level.
Whether these modifications result in structural changes was examined
using SDS-PAGE with silver staining (under both non-reducing and
reducing conditions) or immunoblotting using an anti-murine laminin
antibody (clone AL-2).
SDS-PAGE carried out under non-reducing conditions on samples
treated with both HOCl (Fig. 9A) and the MPO/H2O2/Cl- system
(Fig. 9C), resulted in the detection, by silver staining, of large amounts
of material which migrated only a short distance into the gels from the
loading wells, consistent with the presence of high molecular mass,
intact trimeric laminin-111 protein (Fig. 9A). This material was not
detected under reducing conditions (Fig. 9B,D). Increasing oxidant ex-
posure resulted in modest smearing of this band to lower masses, with
this being most obvious for the HOCl system (Fig. 9A). Under non-re-
ducing conditions, weaker bands were detected at ~ 460 kDa (assigned
to low levels of dissociated α1 chains; red arrows) and ~ 200 kDa (blue
arrows; assigned to β1 and γ1 chains which have similar masses). These
bands do not correspond to the masses indicated by the molecular mass
standards (Fig. 9A,C), as the markers are reduced protein samples,
which migrate at a different rate to the non-reduced proteins. On the
reducing gels (Fig. 9B,D), these lower mass bands migrate at approxi-
mately the expected masses. With increasing oxidant exposure the in-
tensity of the staining of the bands assigned to the α1, β1 and γ1 chains
decreased. These changes were more marked for the samples run under
non-reducing conditions, presumably due to the lower concentrations
of the protein present in a dissociated form. The bands assigned to the
parent α1, β1 and γ1 chains showed increased smearing with higher
oxidant exposure, with this being ascribed to the presence of multiple
proteins conformations, and/or modest changes in molecular mass,
arising from oxidation. A weak band was also detected at low molecular
mass on the reducing gels (Fig. 9B,D), with the staining intensity of this
band increasing with increasing oxidant exposure for both the HOCl
and enzyme systems. The origin of this material is unclear, though it
may be a protein fragment induced by oxidation that is only released
and detected under reducing conditions, possibly as a result of disulfide
bond cleavage.
Immunoblotting of samples separated under reducing conditions
with the rat anti-murine laminin antibody (clone AL-2), provided evi-
dence, for the HOCl system (Fig. 9E), for reduced recognition of the α1
chain on increasing HOCl exposure. The β1 and γ1 chains did not give
rise to significant signals, possibly as a result of the preferential re-
cognition of α1 chain epitopes by this antibody. Corresponding blots
were not carried out on samples separated under non-reducing condi-
tions due to the low intensity of the bands from the dissociated chains,
and the poor migration of the trimeric protein. Immunoblotting ex-
periments with the 2D10G9 antibody did not provide usable data,
consistent with previous experience with this antibody and gels
(Chuang et al., unpublished data).
3.10. In vivo evidence for laminin modification by the MPO/H2O2/Cl-
system
As laminins are major proteins of the BM that underlies the en-
dothelial cells of the artery wall, and the evidence for HOCl-mediated
damage during the development of atherosclerosis [15,26,35,36], we
sought evidence for the presence of laminin, and HOCl-mediated da-
mage to laminin, in human atherosclerotic lesions. Examination of
frozen sections of type II-IV human lesions demonstrated the presence
of high levels of laminin detected by a monoclonal antibody that re-
cognises laminin γ1 in the BM underlying the endothelial cells
(Fig. 10A–C, left panel) and also in the BM of smaller vasa vasorum in
deeper regions of the tissue (Fig. 10C, left panel). When the same tissue
sections were stained for HOCl-generated epitopes, strong fluorescence
was detected in similar regions (Fig. 10A-C, middle panel). In addition
to staining near the surface of the aortae, consistent with the BM, areas
of the vasa vasorum also showed pronounced positivity for HOCl-
modifed epitopes (Fig. 10A-C, middle panel). Merging of images from
Fig. 10A–C (left and middle panel) reveal intense staining for laminin
and HOCl-modified epitopes in close proximity with partial colocali-
zation within the BM underneath the endothelial layers of the aortae
(Fig. 10A-C, right panel) as well as the endothelial layers of vasa va-
sorum (Fig. 10C, right panel). Control experiments in which the pri-
mary antibodies were omitted, or experiments using non-immune
mouse or rabbit IgG, showed no artefactual staining (data not shown).
Fig. 4. (A) Dynamics of 3-ClTyr and 3,5-Cl2Tyr formation
on peptide 630AEGLSLQPYEEYFNVVR646 detected on oxi-
dation of murine laminin-111 (1.18 μM) treated with 0,
100, and 500 μM HOCl. (B) Relative site occupancy of
different chlorination products detected at Tyr638 and
Tyr641 on treatment of murine laminin-111 (1.18 μM) with
0.1 μM MPO, 500 μM H2O2, and 100mM NaCl.
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Fig. 5. Fragment ion spectra of the peptide 2081DMEMQANLLLDR2092 from murine laminin-111 for: (A) the native peptide, (B), peptide with mono-oxygenation
(sulfoxide formation) at Met2082, and (C) peptide with mono-oxygenation (sulfoxide formation) at Met2084. Data from murine laminin-111 (1.18 μM) treated with 0,
100, and 500 μM HOCl. Annotated MS/MS spectra and fragment ion tables for all identified peptides are available in Supplementary Fig. 4.
Fig. 6. Concentration dependence of mod-
ifications at Met residues in the peptides: (A)
2081DMEMQANLLLDR2092 and (B) 1476KQDD-
ADQDMMMAGMASQAAQEAELNAR1502. In
(A), the Met residues at position 2084 and
2082 appear to be modified sequentially and in
this order. In (B), modification occurs at each
of the 4 Met residues with little apparent site
specificity at any of the Met residues. With
increasing HOCl exposure all 4 Met residues
become oxidised. Data from murine laminin-
111 (1.18 μM) treated with 0, 100, and 500 μM
HOCl as indicated.
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4. Discussion
Previous studies have provided compelling evidence for a strong
association between the levels of MPO (which is released by activated
phagocytes at sites of inflammation), and the oxidants it generates, with
the development of atherosclerosis (e.g. [15,16,26,28,32,35,68,69].
Rupture of atherosclerotic lesions is a major cause of heart attack and
stroke, and sudden cardiac death. It has been shown that blood or
plasma/serum levels of MPO can be both diagnostic of major cardio-
vascular diseases, and predictive of adverse outcomes (e.g. [28,30,70]).
As MPO is released from intracellular storage granules into phagoly-
sosomes or extracellularly [22], and binds strongly to ECM components
[61,71], it would be expected that the oxidants generated by this en-
zyme would target matrix materials. Considerable data support this
hypothesis [42,48,61,62,71]. Evidence has also been presented for ECM
damage by other oxidants associated with both normal metabolism and
inflammation, such as peroxynitrous acid, and for the presence of
modified ECM species in human atherosclerotic lesions (e.g.
[6,7,9–11,72]). However the exact nature, sites and extents of mod-
ification induced by MPO and its oxidants (e.g. HOCl) on ECM materials
such as laminin, the major basement membrane protein, are poorly
characterized. As a consequence we have determined the sites and ex-
tent of oxidation and chlorination induced by both reagent HOCl and
the MPO/H2O2/Cl- system on purified laminin-111, and this protein
present in BME. We have also examined possible structural changes
induced by oxidant exposure, and the potential presence of HOCl-
modified laminins in human atherosclerotic lesions.
The data obtained indicate that some sites on laminin-111 are more
susceptible to modification than others, as judged by both the site-
specificity and extent of modification as determined by RSO. Treatment
with reagent HOCl resulted in the detection, by MS mass mapping, of
oxidation at 30 Met and 7 Trp residues, and chlorination of 33 Tyr
residues (with 3 Tyr also detected as 3,5-Cl2Tyr), out of the 56 Met, 24
Trp and 99 Tyr residues present in the native protein. Treatment of the
isolated laminin-111 with the MPO/H2O2/Cl- system, supplied with
500 μM H2O2 to give ~ 500 μM HOCl, showed some similarities, and
also some significant differences, with the regard to the both the sites
and extents of modification. This may be due to an association or
binding of MPO to particular sequences within the trimeric laminin
structure. A recent study, using an identical MS approach, quantified
modifications induced by reagent HOCl, versus MPO/H2O2/Cl- on
human plasma fibronectin, showed an overall decrease in the number of
sites, and extent of modification, [48]. In contrast, for laminin, a sig-
nificant increase in the number of sites, and a greater extent of mod-
ification were observed with MPO/H2O2/Cl- compared to HOCl. Thus,
an additional 8 Met and 10 Trp oxidation sites, and 14 3-ClTyr, and 18
3,5-Cl2Tyr positions were detected with MPO/H2O2/Cl- with an iden-
tical initial amount of added H2O2 (and hence HOCl formed, as judged
by the quantification of oxidant formation using monochlorodimedone
or 3,3′,5,5′-tetramethylbenzidine [48]). This increase in number and
extent of modifications is surprising, as MPO protein might be expected
to act as an alternative target for the generated oxidant, and therefore
diminish the oxidant concentration available for reaction with the la-
minin. It is unclear, at present, why there are these differences. It is
possible that interactions between MPO and the ECM proteins, results
in a higher concentration or efficiency of oxidant formation in the case
of association with laminin, and/or that association of MPO with fi-
bronectin inhibits MPO activity and thereby decreases the extent of
fibronectin modification (cf. the inhibition, via complex formation of
plasma ceruloplasmin on MPO activity [73,74]).
Both the MS and amino acid analyses indicate that Met residues are
Fig. 7. Quantification of total (A) parent Met, (B) formation of Met sulfoxide, and (C) 3-ClTyr formation, in laminin-111 as determined by amino acid analysis (panels
A,B: UPLC with pre-column fluorescence tagging; panel C: by LC-MS) after total protein digestion using methane sulfonic acid (MSA). Data from murine laminin-111
(25 μg in 50 μL) treated without (control) or with MPO (100 nM)/H2O2 (500-fold molar excess over laminin), added in multiple aliquots)/Cl- (100mM) for 2 h at
37 °C in 100mM PBS, pH 7.4. For further details see Materials and methods. * Indicates statistical significance against the control (non-oxidised) sample at the
p < 0.05 level, as determined by one-way ANOVA with post-hoc analysis using Dunnett's multiple comparison test, using data from 3 independent experiments.
Fig. 8. Detection of HOCl-mediated damage to laminin-111 incubated with a
MPO/H2O2/Cl- system by use of ELISA employing the monoclonal antibody
2D10G9. Laminin-111 (25 μg in 50 μL) was treated with MPO (20 nM)/H2O2 (at
the indicated concentrations, added in multiple aliquots)/Cl- (100mM) for 2 h
at 37 °C in 100mM PBS, pH 7.4. Samples were then probed for epitopes re-
cognised by 2D10G9 as described in the Materials and methods and determi-
nation of the absorbance at 405 nm. * Indicates statistical significance against
the control (non-oxidised) sample at the p < 0.05 level, as determined by one-
way ANOVA with post-hoc analysis using Dunnett's multiple comparison test,
using data from 3 independent experiments.
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a major target for HOCl with this protein; this is in accord with the high
rate constant for reaction of HOCl with this side-chain (k
3×107–1×108 M−1 s−1 [23,75]. Cys and cystine are also highly re-
active with HOCl [23,75,76], with k for Cys (typically) higher than for
Met [75]. However, there is a very low abundance of Cys (but a mod-
erate number of cystine) residues in laminin, and other ECM proteins in
general, suggesting that these do not consume a significant amount of
the HOCl provided. This does not however preclude reaction at the few
Cys residues being functionally important. The rate constants, k, for
reaction of HOCl with disulfides vary significantly with their environ-
ment (e.g. presence of neighboring groups) and conformation [76],
suggesting that the cystine groups present in the laminin EGF-like (EL)
domains of laminin may be significant targets. Reaction at such sites is
however difficult to detect and quantify due to the cross-linked nature
of these structures, and the destruction of these modifications during
the standard “reduce and alkylate” protocols of most MS mass mapping
approaches. New approaches are therefore needed to test this
suggestion.
The quantitative data obtained from the amino acid analyses in-
dicate that ~ 15% of the HOCl generated by the enzyme system, is
consumed by Met residues. 3-ClTyr formation accounts for an addi-
tional ~ 0.2%, with an additional (not quantified) small amount used to
convert 3-ClTyr to 3,5-diClTyr. A similar analysis was not carried out
for Trp. These data, together with that from the MS mass mapping,
indicate that the products detected account for only a modest amount of
the HOCl added or generated. A significant proportion of the “missing”
HOCl is likely to have reacted with Lys, His (and possibly Arg) residues,
as these are important kinetic targets [23,24], and highly abundant in
laminin-111 (cf. 316 Lys, 161 His residues; data from Uniprot entries
P19137, P02469, P02468). Reaction at these residues gives unstable
chloramines (RNHCl species, and dichloramines, RNCl2, at higher oxi-
dant concentrations) that decay over minutes-hours. Decomposition of
these species yields multiple materials, including regeneration of the
parent amino acid, radicals [77,78], carbonyl compounds [77,79–81],
Fig. 9. Structural changes induced on laminin-111 and individual laminin chains induced by reagent HOCl (panels A,B) or a MPO/H2O2/Cl- system (panels C,D)
detected by SDS-PAGE run under non-reducing (panels A,C) or reducing conditions (panels B,D) with detection of protein bands by silver staining. Laminin-111
(2.5 μg in 50 μL) was treated with reagent HOCl at the indicated molar excesses (panels A,B) or for panels (C,D) with a MPO (100 nM)/H2O2 (at the indicated molar
excesses, added in multiple aliquots)/Cl- (100mM) system for 2 h at 37 °C in 100mM PBS, pH 7.4, before analysis. In panels A-D, the lane labelled “C” is control, non-
oxidised protein. In panels C,D, the lane labelled “MPO-“ is the complete reaction system without MPO (i.e. laminin incubated with H2O2 alone). The extreme left
lane (and extreme right lane for panels A,B) on each gel contains molecular mass markers for reduced proteins of the indicated masses. Red arrows indicate the bands
assigned to the α1 chains, and the blue arrows indicate bands assigned to the β1 and γ1 chains that have very similar masses. Panel E: Reaction system as panel B (i.e.
treatment of laminin-111 with reagent HOCl at the indicated molar excesses, and SDS-PAGE separation run under reducing conditions) except the resulting gel was
blotted and probed for recognition of laminin chains using a rat anti-murine laminin monoclonal antibody (clone AL-2) and subsequent chemiluminescence detection
(for details see Materials and methods). The major band detected is from the α1 chain. Representative gels and blots are presented, typical of 3 independent
experiments.
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carboxylic acids [82], and nitriles [82]. This complexity makes quan-
tification complex [77–79].
Mapping of the detected modifications onto a complete 3D structure
cannot be accomplished at present, as only a small number of partial
structures are available. A recently structure (PDB entry: 5MC9) [83]
contains the coordinates of the xLG1–3 domains, as well as ~50 re-
sidues of the coiled coil (α1β1γ1). These sequences contain 20 Tyr, of
which 11 were identified as chlorination targets, 14 Met, of which 7
were detected as sulfoxides, and 4 Trp, with 3 of these detected as
oxidised species (Fig. 11A, Supplementary Fig. 8). While most of these
modified residues appear to be surface exposed, Tyr2138, Tyr2147,
Trp2293, Tyr2295, and Met2554, which were detected as modified species
with both HOCl and MPO/H2O2/Cl-, appear to be buried within the
structure; this is also true for Met2179, which was modified solely by the
enzyme system. These data indicate either that (neutral) HOCl can
penetrate and react within the interior of a protein, or that the crystal
structure represents a “snap shot” of a system with considerable flex-
ibility. The detection of modifications to (surface-exposed) Tyr2415 is of
particular interest as it is situated close to Glu1605 (indicated in brown,
in Fig. 11, panel A), which is essential for interactions with integrins
[83–85]. Modification of this residue, and possibly others nearby, may
therefore affect integrin binding to laminins, and hence cell binding to
the ECM [4,85].
Similar analyses (Fig. 11, panels B-E) have been carried out using
the structures of the short arms of the β1 and γ1 chains (PDB entries:
4AQS and 4AQT [86]), which contain both the N-terminal (LN) and
part of the first EL-like domains. As little sequence coverage (and hence
no modifications) was obtained for the LE domains due to the presence
of disulfide bonds (cf. Fig. 1), the renderings of these structures are
displayed both with the LE domains included, and with these greyed
out (Fig. 11B-E). The β1 structure contains 12 Tyr, 5 Met, and 4 Trp
residues, with 3-ClTyr formation detected at 3 Tyr (Tyr-220, Tyr-259,
Tyr 263) and sulfoxide formation at 3 Met (Met-148, Met-182, Met-
265). The γ1 structures contains 13 Tyr, 2 Met, and 4 Trp, with 4 of the
Tyr residues detected as 3-ClTyr (Tyr-145, Tyr-230, Tyr-272, Tyr-273).
Interestingly, the sites that were most readily modified are, in general,
not those that are most surface-exposed. The majority of the mod-
ifications detected are present in the highly conserved portions of both
structures that appear to be involved in binding to other chains [86].
Laminin polymerisation has been proposed to occur, at least in vitro,
via a two-step process initiated by association of the β and γ chains
through the LN-terminal domains, followed by association with the α
chains [87], so these data suggest that the ECM assembly may be af-
fected by modifications in the LN domains.
The LE domains contain a large number of Tyr and Trp residues,
which may be potential modification targets overlooked by the current
method. The LE domains are highly preserved structural elements
present in a wide array of extracellular proteins [88,89], and are known
to mediate in the case of laminin γ1, binding to other BM materials such
as nidogen [90]. Modification to the LE domains may therefore have
functional consequences and stresses the need for efficient methods to
analyse disulfide-rich peptides.
Fig. 10. Immunofluorescence staining for la-
minin and HOCl-modified proteins and co-lo-
calization in human type II-IV atherosclerotic
lesions. Five μm frozen sections of arteria fe-
muralis (A, autopsy material of a 80-year-old
female patient, type II-III; B, autopsy material
of a 56-year-old female patient, type II-III) and
aorta abdominalis (C, autopsy material of a 74-
year-old male patient, type III-IV) were in-
cubated with anti-laminin mAb (clone 2E8,
Merck-Millipore, dilution 1:100, A-C, left
panel) and detected with a goat anti-mouse Cy-
2 labelled antibody (1:300, green). HOCl-
modified proteins were detected using Cy-3-
labelled monoclonal antibody (clone 2D10G9,
dilution 1:100, red, A-C, middle panel). Right
panels (A-C) show the resulting overlay
(merge) of laminin (green) and HOCl-modified
proteins (red). White arrows indicate vasa va-
sorum.
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The potential functional importance of these modifications is in-
dicated by enhanced recognition of modified laminin-111 by the
2D10G9 antibody that recognises HOCl-mediated damage (Fig. 9), and
the detection of material recognised by this antibody in human type II-
IV atherosclerotic lesions (Fig. 10). The close co-localization of epitopes
recognised by 2D10G9 with those recognised by a laminin antibody in
human lesion material provides strong support for the presence of
HOCl-modified laminin and other extracellular matrix materials in this
major human disease. Whether this is a contributing factor to the dis-
ease or merely a consequence of ongoing oxidation within the artery
wall remains to be established, however it is well established that en-
dothelial cell dysfunction and denudation are key early events in the
development of atherosclerosis, and it is possible that modifications to
the integrin binding site, as detected here, may be a key factor in the
known loss of endothelial cell adherence.
Fig. 11. Mapping of all (parent and modified)
Tyr, Met and Trp residues (colour coded as
indicated) onto (A) the crystal structure (data
from PDB entry: 9MC5) of the LG1–3 domain
and the first 50 residues of the coiled-coil, (B,
D) the LN domain of the β1 chain (PDB entry:
4AQS) and (C, E) the LN domain of the γ1
chain (PDB entry: 4AQT). Attached glycan
chains are indicated as brown stick structures,
and the key integrin binding residue Glu1605
(panel A) are also indicated. For the β1 and γ1
structures presented in panels D and E, the
residues that interact with the LE domains (and
hence might be expected to be protected from
modification in the entire protein structure),
are indicated in grey. The indicated modifica-
tions at Tyr, Met and Trp are those induced by
treatment of murine laminin-111 (1.18 μM)
with 0.1 μM MPO and 500 μM H2O2, in the
presence of 100mM NaCl, in 100mM PBS, pH
7.4, for 1 h.
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